- Investing Ideas
- Australian Pharmaceuticals & Biotech Nano Cap Stocks
Australian Pharmaceuticals & Biotech Nano Cap Stocks
Results
6
Stocks with a market cap under US$50M.
6 companies
Little Green Pharma
Market Cap: AU$58.0m
Produces and sells cannabis-based medicinal products across Australia and Europe.
LGP
AU$0.07
7D
-2.8%
1Y
-42.9%
Botanix Pharmaceuticals
Market Cap: AU$54.7m
Operates as a commercial dermatology company in Australia and the United States.
BOT
AU$0.02
7D
-4.8%
1Y
-87.1%
Medical Developments International
Market Cap: AU$53.5m
Provides emergency medical solutions in Australia, Europe, the United States, and internationally.
MVP
AU$0.50
7D
8.7%
1Y
-21.3%
Radiopharm Theranostics
Market Cap: AU$43.4m
A clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs.
RAD
AU$0.011
7D
0%
1Y
-60.7%
Trajan Group Holdings
Market Cap: AU$27.5m
Develops, manufactures, and sells analytical and life science products and devices in Malaysia, Japan, Australia, New Zealand, the United States, Europe, the Middle East, Africa, and India.
TRJ
AU$0.18
7D
-7.7%
1Y
-80.9%
Vitura Health
Market Cap: AU$16.6m
Engages in the sale and distribution of medicinal cannabis products in Australia.
VIT
AU$0.028
7D
16.7%
1Y
-60.3%